Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Intravenous Fentanyl for Oxidative Stress in Preterm Neonates
NCT07148882Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2024
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fentanyl citrate nasal spray in procedural pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Malondialdehyde Level at 30 months. Started Feb 2024; status: completed.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT07148882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07148882.